The phosphaturic hormone FGF-23 is another promising biomarker linked to left ventricular hypertrophy, myocardial fibrosis, and cardiovascular mortality, especially in renal dysfunction [32,33,34]. The gene discussed is FGF23; the disease is left ventricular hypertrophy.